| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $375.7M | +7.3% |
| Cost of Revenue | $257.3M | +11.9% |
| Gross Profit | $118.4M | -1.6% |
| R&D Expense | $56.1M | +19.3% |
| SG&A Expense | $85.4M | -5.4% |
| Operating Income | -$32.2M | +0.3% |
| Pre-tax Income | -$35.4M | -12.6% |
| Income Tax | $2.0M | -37.8% |
| Net Income | -$37.4M | -7.9% |
| EPS (Basic) | -$1.33 | -2.3% |
| EPS (Diluted) | -$1.33 | -2.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.3M | -26.4% |
| Inventory | $78.5M | +38.0% |
| Current Assets | $295.7M | +37.6% |
| Total Assets | $385.0M | +49.4% |
| Current Liabilities | $209.2M | +131.2% |
| Long-term Debt | $24.4M | — |
| Total Liabilities | $242.3M | +92.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.9M | -255.3% |
| Capital Expenditures | $4.5M | -18.9% |
| Investing Cash Flow | -$28.0M | -195.4% |
| Financing Cash Flow | $64.8M | +172.4% |
| Free Cash Flow | -$55.4M | -178.4% |
| Stockholders' Equity |
| $142.7M |
| +8.2% |